Olaparib nanoparticles potentiated radiosensitization effects on lung cancer

References

• JemalABrayFCenterMMGlobal cancer statisticsCA Cancer J Clin2011612699021296855
   PubMed Web of Science ®Google Scholar
• LeeWHLooCYOngHXSynthesis and characterization of inhalable flavonoid nanoparticle for lung cancer cell targetingJ Biomed Nanotechnol201612237138627305771
   PubMed Web of Science ®Google Scholar
• HerbstRSHeymachJVLippmanSMLung cancerN Engl J Med2008359131367138018815398
   PubMed Web of Science ®Google Scholar
• KleinCDokicIMairaniAOvercoming hypoxia-induced tumor radioresistance in non-small cell lung cancer by targeting DNA-dependent protein kinase in combination with carbon ion irradiationRadiat Oncol201712120829287602
   PubMedGoogle Scholar
• JiangYVerbiestTDeveryAMHypoxia potentiates the radiation-sensitizing effect of olaparib in human non-small cell lung cancer xenografts by contextual synthetic lethalityInt J Radiat Oncol Biol Phys201695277278127020103
   PubMed Web of Science ®Google Scholar
• PrasadCBPrasadSBYadavSSOlaparib modulates DNA repair efficiency, sensitizes cervical cancer cells to cisplatin and exhibits anti-metastatic propertySci Rep201771287628993682
   PubMed Web of Science ®Google Scholar
• GravellsPNealeJGrantERadiosensitization with an inhibitor of poly(ADP-ribose) glycohydrolase: a comparison with the PARP1/2/3 inhibitor olaparibDNA Repair201861253629179156
   PubMed Web of Science ®Google Scholar
• KimGIsonGMcKeeAEFDA Approval summary: olaparib monotherapy in patients with deleterious germline BRCA-mutated advanced ovarian cancer treated with three or more lines of chemotherapyClin Cancer Res201521194257426126187614
   PubMed Web of Science ®Google Scholar
• LiuJFBarryWTBirrerMCombination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 studyLancet Oncol201415111207121425218906
   PubMed Web of Science ®Google Scholar
• KobayashiHChoykePLSuper enhanced permeability and retention (SUPR) effects in tumors following near infrared photoimmunotherapyNanoscale2016825125041250926443992
   PubMed Web of Science ®Google Scholar
• ChenLZangFWuHUsing PEGylated magnetic nanoparticles to describe the EPR effect in tumor for predicting therapeutic efficacy of micelle drugsNanoscale20181041788179729308812
   PubMed Web of Science ®Google Scholar
• NiXLChenLXZhangHIn vitro and in vivo antitumor effect of gefitinib nanoparticles on human lung cancerDrug Deliv20172411501151228961023
   PubMed Web of Science ®Google Scholar
• ZhangHJiangYNiXGlycyrrhetinic acid-modified norcantharidin nanoparticles for active targeted therapy of hepatocellular carcinomaJ Biomed Nanotechnol201814111412629463369
   PubMed Web of Science ®Google Scholar
• GongCXieYWuQImproving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinomaNanoscale20124196004601722910790
   PubMed Web of Science ®Google Scholar
• GaoXWangBWeiXAnticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancerNanoscale20124227021703023044718
   PubMed Web of Science ®Google Scholar
• GaniCCoackleyCKumareswaranRIn vivo studies of the PARP inhibitor, AZD-2281, in combination with fractionated radiotherapy: an exploration of the therapeutic ratioRadiother Oncol2015116348649426277432
   PubMed Web of Science ®Google Scholar
• SenraJMTelferBACherryKEInhibition of PARP-1 by olaparib (AZD2281) increases the radiosensitivity of a lung tumor xenograftMol Cancer Ther201110101949195821825006
   PubMed Web of Science ®Google Scholar
• ZhangXYangHGuKIn vitro and in vivo study of a nano-liposomal cisplatin as a radiosensitizerInt J Nanomedicine2011643744421499433
   PubMed Web of Science ®Google Scholar
• XuSTangYYYuYXYxYNovel composite drug delivery system as a novel radio sensitizer for the local treatment of cervical carcinomaDrug Deliv20172411139114728797171
   PubMed Web of Science ®Google Scholar
• DiabRHamoudehMBoyronOElaissariAFessiHMicroen-capsulation of cytarabine using poly(ethylene glycol)-poly(epsilon-caprolactone) diblock copolymers as surfactant agentsDrug Dev Ind Pharm201036445646919877831
   PubMed Web of Science ®Google Scholar
• ItoMJiangCKrummKTIP30 deficiency increases susceptibility to tumorigenesisCancer Res200363248763876714695192
   PubMed Web of Science ®Google Scholar
• ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
   PubMed Web of Science ®Google Scholar
• HelledayTLoJvan GentDCEngelwardBPDNA double-strand break repair: from mechanistic understanding to cancer treatmentDNA Repair20076792393517363343
   PubMed Web of Science ®Google Scholar
• HühnDBolckHASartoriAATargeting DNA double-strand break signalling and repair: recent advances in cancer therapySwiss Med Wkly2013143w1383723897299
   PubMed Web of Science ®Google Scholar
• YuYXuSYouHIn vivo synergistic anti-tumor effect of paclitaxel nanoparticles combined with radiotherapy on human cervical carcinomaDrug Deliv2017241758228155566
   PubMed Web of Science ®Google Scholar
• YouHFuSQinXA study of the synergistic effect of folate-decorated polymeric micelles incorporating hydroxycamptothecin with radiotherapy on xenografted human cervical carcinomaColloids Surf B Biointerfaces201614015016026752212
   PubMed Web of Science ®Google Scholar
• WuZZouXYangLThermosensitive hydrogel used in dual drug delivery system with paclitaxel-loaded micelles for in situ treatment of lung cancerColloids Surf B Biointerfaces2014122909825033428
   PubMed Web of Science ®Google Scholar
• WangYWangCWangYMicelles of methoxy poly(ethylene glycol)-poly(epsilon-caprolactone) as a novel drug delivery vehicle for tacrolimusJ Biomed Nanotechnol20139214715723627041
   PubMed Web of Science ®Google Scholar
• van de VenALTangutooriSBaldwinPNanoformulation of olaparib amplifies PARP inhibition and sensitizes PTEN/TP53-deficient prostate cancer to radiationMol Cancer Ther20171671279128928500233
   PubMed Web of Science ®Google Scholar
• UllalAVReinerTYangKSNanoparticle-mediated measurement of target-drug binding in cancer cellsACS Nano20115119216922421962084
   PubMed Web of Science ®Google Scholar
• YangQLiaoJDengXAnti-tumor activity and safety evaluation of fisetin-loaded methoxy poly(ethylene glycol)-poly(epsilon-caprolactone) nanoparticlesJ Biomed Nanotechnol201410458059124734510
   PubMed Web of Science ®Google Scholar
• WangYWuMGuLEffective improvement of the neuroprotective activity after spinal cord injury by synergistic effect of glucocorticoid with biodegradable amphipathic nanomicellesDrug Deliv201724139140128165815
   PubMed Web of Science ®Google Scholar
• ChenLXNiXLZhangHPreparation, characterization, in vitro and in vivo anti-tumor effect of thalidomide nanoparticles on lung cancerInt J Nanomedicine2018132463247629719394
   PubMed Web of Science ®Google Scholar
• XiaYWuXZhaoJThree dimensional plasmonic assemblies of AuNPs with an overall size of sub-200 nm for chemo-photothermal synergistic therapy of breast cancerNanoscale2016844186821869227786323
   PubMed Web of Science ®Google Scholar
• XuZLiuSKangYWangMGlutathione- and pH-responsive nonporous silica prodrug nanoparticles for controlled release and cancer therapyNanoscale20157135859586825757484
   PubMed Web of Science ®Google Scholar
• ZhangZFengSSNanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug releaseBiomaterials200627226227016024075
   PubMed Web of Science ®Google Scholar
• MuLFengSSVitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol)J Control Release2002801–312914411943393
   PubMed Web of Science ®Google Scholar
• Van den AbbeeleADThe lessons of GIST – PET and PET/CT: a new paradigm for imagingOncologist200813Suppl 281318434632
   PubMed Web of Science ®Google Scholar
• LöserDAShibataAShibataAKSensitization to radiation and alkylating agents by inhibitors of poly(ADP-ribose) polymerase is enhanced in cells deficient in DNA double-strand break repairMol Cancer Ther2010961775178720530711
   PubMed Web of Science ®Google Scholar
• Glatzel-PlucinskaNPiotrowskaAGrzegrzolkaJSATB1 level correlates with Ki-67 expression and is a positive prognostic factor in non-small cell lung carcinomaAnticancer Res201838272373629374696
   PubMed Web of Science ®Google Scholar
• XieFDingRLHeWFIn vivo antitumor effect of endostatin-loaded chitosan nanoparticles combined with paclitaxel on Lewis lung carcinomaDrug Deliv20172411410141828933203
   PubMed Web of Science ®Google Scholar
• SunCJYangZGZhouXPNon-small cell lung cancer evaluated by first pass dynamic contrast-enhanced 16-slice spiral CT: correlation of tumor vascularity with pathological characteristicsZhonghua Zhong Liu Za Zhi200729642943317974276
   PubMedGoogle Scholar
• RanjanAPMukerjeeAGdowskiACurcumin-ER prolonged subcutaneous delivery for the treatment of non-small cell lung cancerJ Biomed Nanotechnol201612467968827301194
   PubMed Web of Science ®Google Scholar
• ChalmersAJohnstonPWoodcockMJoinerMMarplesBPARP-1, PARP-2, and the cellular response to low doses of ionizing radiationInt J Radiat Oncol Biol Phys200458241041914751510
   PubMed Web of Science ®Google Scholar
• LinSYanYLiuYSensitisation of human lung adenocarcinoma A549 cells to radiotherapy by Nimotuzumab is associated with enhanced apoptosis and cell cycle arrest in the G2/M phaseCell Biol Int201539214615125044496
   PubMed Web of Science ®Google Scholar
• DebenCLardonFWoutersAAPR-246 (PRIMA-1(MET)) strongly synergizes with AZD2281 (olaparib) induced PARP inhibition to induce apoptosis in non-small cell lung cancer cell linesCancer Lett2016375231332226975633
   PubMed Web of Science ®Google Scholar
• KumarCGPoornachandraYChandrasekharCGreen synthesis of bacterial mediated anti-proliferative gold nanoparticles: inducing mitotic arrest (G2/M phase) and apoptosis (intrinsic pathway)Nanoscale2015744187381875026503300
   PubMed Web of Science ®Google Scholar